We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type

3 results found


Duane Morris LLP | USA | 2 Aug 2011

Federal Circuit reverses N.Y. district court: claims to "isolated" DNA are eligible for patent protection

On July 29, 2011, the U.S. Court of Appeals for the Federal Circuit reversed in part the U.S. District Court for the Southern District of New York's ruling in Association for Molecular Pathology v. USPTO, Myriad Genetics, et al. ("Myriad") and held that claims to "isolated" DNA molecules were patent-eligible.

Previous page 1 Next page